Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.9 USD | +0.32% | +1.84% | -6.90% |
05-21 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
05-14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.90% | 17.56B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.70% | 21.97B | |
-4.55% | 19.27B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B | |
-29.20% | 7.77B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- US FDA Approves BeiGene's Lymphocytic Leukemia Treatment